Are sutureless securement devices effective at reducing BSI and improving CVAD securement?
A systematic review and meta-analysis reported that sutureless securement devices may reduce the risk of entry/exit site infections and improve catheter securement compared with dressings alone (Xu et al, 2024). Again, most studies were from ICU and cancer care settings, so more research is required to assess the relative effects of dressing and securement products for CVADs in other clinical and community settings.
A subcutaneous anchor securement system (SecurAcath), with blunt ‘feet’ inserted under the skin to provide stabilisation at the point of insertion, is another sutureless securement option for CVADs, particularly those with medium- or long-term dwell times. In paediatric patients, a large randomised controlled trial found nontunnelled CVADs (PICCs and CVCs) secured with SecurAcath were five times less likely to dislodge than those secured with a sutureless securement device (e.g., StatLock) (Kleidon et al, 2024). While some observational studies have shown decreased dislodgement and reduced infection with SecurAcath use, more high-quality prospective research needs to be conducted to determine efficacy in adult patients and across other CVAD types.
Curious about the best dressings and ideal change frequency for CVADs? Discover more here.
References:
Last Updated on: 06/11/2024